RecruitingNCT05589181
High-dose or standard buprenorphine for fentanyl use in the emergency department
About this title
Read the official source — NCT05589181Medication studyAges 18+United StatesAddiction
Understand this study
Who could participate?
Listed age limits: from 18 years.
- Listed locations
- NewarkSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: April 6, 2023
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 140
- Sponsor
- Rutgers, The State University of New Jersey
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT05589181
- Official title
Show the full official title
Safety and Efficacy of High Dose Buprenorphine Induction in Fentanyl Positive Emergency Department Patients
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Newark
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Rutgers, The State University of New Jersey, a university.
Does this study involve medication?
Yes. The study involves medication, including High Dose Buprenorphine and Standard Buprenorphine Dose.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as recruiting.
